United Therapeutics Corp (UTHR) Easily Beats Q3 Views; Revs Top $200M
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $501.27 -2.04%
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Research and development: 45.9M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q3 EPS of $1.65, $0.92 better than the analyst estimate of $0.73. Revenue for the quarter came in at $201.7 million versus the consensus estimate of $194.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
